Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations

Stem Cell Research(2023)10.1016/j.scr.2023.103246Source: DataRank Database

Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations is a research paper published in Stem Cell Research (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

hPSCreg

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.18)OA: goldTopics (90)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ravichandra Venkateshappa ORCID,Audrey Li,Michael B. Fowler,Melinda L. Telli ORCID,Joseph C. Wu ORCID

Live enrichment

PubMed:37951143 PMC:PMC10789563 OpenAlex:https://openalex.org/W4388419999

National Institutes of Health

Grant: 75N92020D00019

National Institutes of Health

Grant: R01 HL141371

National Institutes of Health

Grant: R01 HL141851

National Institutes of Health

Grant: R01 HL150693

National Institutes of Health

Grant: R01 HL163680

Tobacco-Related Disease Research Program

Grant: T32FT4853

National Institutes of Health

Grant: 1R01HL141371-01

Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes

National Institutes of Health

Grant: 1R01HL163680-01

Elucidating ECM Signaling in Cardiac Organoids with Machine Learning and Single-cell Multiomics

National Institutes of Health

Grant: 5R01HL150693-02

Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening

National Institutes of Health

Grant: 5R01HL141851-07

Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.scr.2023.103246

publisherhttps://doi.org/10.1016/j.scr.2023.103246

publisherhttps://api.elsevier.com/content/article/PII:S1873506123002325?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1873506123002325?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37951143

Fields of Study

Pluripotent Stem Cells ResearchMicrotubule and mitosis dynamicsCRISPR and Genetic Engineering0303 health sciences03 medical and health sciencesHumansFemaleInduced Pluripotent Stem CellsBreast NeoplasmsLeukocytes, MononuclearMutationGerm-Line MutationAtaxia Telangiectasia Mutated Proteins

MeSH Terms

Breast NeoplasmsFemaleHumansLeukocytes, MononuclearMutationGerm-Line MutationInduced Pluripotent Stem CellsAtaxia Telangiectasia Mutated Proteins

Keywords

BiologyInduced pluripotent stem cellGerm layerGermlinePeripheral blood mononuclear cellBreast cancerCancer researchCancerKaryotypeMutationStem cellGeneticsGeneEmbryonic stem cellIn vitroChromosomeWomen's Health (rcdc)Stem Cell Research - Induced Pluripotent Stem Cell - Human (rcdc)Ataxia Telangiectasia Mutated ProteinsRegenerative Medicine11 Medical and Health Sciences (for)Medical and Health Sciences3105 Genetics (for-2020)Clinical Research (rcdc)Regenerative Medicine (rcdc)Leukocytes2.1 Biological and endogenous factorsBiology (General)32 Biomedical and Clinical Sciences (for-2020)Developmental Biology (science-metrix)Cancer (rcdc)Humans (mesh)Stem Cell Research - Induced Pluripotent Stem Cell - HumanMutation (mesh)3206 Medical biotechnology (for-2020)Biological SciencesInduced Pluripotent Stem Cells (mesh)06 Biological Sciences (for)Breast Cancer (rcdc)Germ-Line Mutation (mesh)FemaleQH301-705.5Oncology and CarcinogenesisMononuclearStem Cell Research - Induced Pluripotent Stem Cell (rcdc)Induced Pluripotent Stem CellsMedical biotechnology610Breast NeoplasmsArticle618Breast Neoplasms (mesh)Clinical Research3211 Oncology and carcinogenesis (for-2020)HumansGerm-Line MutationBiomedical and Clinical SciencesStem Cell Research - Induced Pluripotent Stem CellGenetics (rcdc)2.1 Biological and endogenous factors (hrcs-rac)Cancer (hrcs-hc)Stem Cell ResearchStem Cell Research (rcdc)Mononuclear (mesh)Female (mesh)Leukocytes, MononuclearWomen's HealthAtaxia Telangiectasia Mutated Proteins (mesh)Developmental Biology

Sustainable Development Goals

SDG 0: Good health and well-being

Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations

FAIR Checklist

Authors (6)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)